Table 2. Demographics.
| Case | Age/gender | Race/birth geographic region | Hepatitis/cirrhosis | CA19-9 elevation baseline | AFP elevation baseline |
|---|---|---|---|---|---|
| 1 | 64/male | Caucasian/USA | + HCV/+ cirrhosis | NR | NR |
| 2 | 52/female | Caucasian/USA | None | No | No |
| 3 | 34/female | Asian/China | + HBV | Yes | Yes |
| 4 | 57/female | Caucasian/USA | None | NR | NR |
| 5 | 56/male | Caucasian/USA | + HCV/+ cirrhosis | Yes | Yes |
| 6 | 49/male | Asian/Southeast Asia | + HCV/+ cirrhosis | Yes | Yes |
| 7 | 61/female | Caucasian/USA | None | NR | NR |
CA19-9, carbohydrate antigen 19-9; AFP, alpha-fetoprotein; HCV, hepatitis C virus; HBV, hepatitis B virus; NR, not reported; USA, United States of America.